Dr. Eric Topol is back in the spotlight. Tuesday evening, the chief academic officer of Scripps Health in San Diego, director of the Scripps Translational Science Institute and editor-in-chief of Medscape.com, appeared on “Mad Money” with CNBC dervish Jim Cramer.
Cramer said he had Topol on because the latter’s current book, “The Patient Will See You Now,” was “groundbreaking.” According to Cramer, “I think this book is revelatory and just plain smart.”
Topol showed up with a few gadgets and smartphone apps that are helping to democratize medicine. On the horizon is a ring-type device from Finland that can measure sleep patterns as well as any sleep clinic, Topol said. “We can do so much better with this mobile technology in your own setting,” he explained.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Topol and Cramer name-checked a few digital health companies, including Teladoc and Theranos. He called Theranos a driver behind the “creative destruction of lab medicine.” (Theranos CEO Elizabeth Holmes was on CNBC earlier Tuesday.)
They also talked how genomics could lower the cost of orphan drugs as well as how patients can generate their own health data at home.
Watch the interview here:
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Photo: Twitter user Eric Topol
